University of Zurich Study Identifies Physician Recommendations as Primary Driver for Adult HPV Vaccination Success
University of Zurich researchers find that many adults miss out on life-saving HPV vaccines simply because their doctors never recommended the treatment.
By: AXL Media
Published: Mar 26, 2026, 10:19 AM EDT
Source: Information for this report was sourced from University of Zurich

Current Landscape of HPV Immunization in Switzerland
A comprehensive study conducted by the University of Zurich has found that approximately one in four adults in Switzerland has received at least one dose of the human papillomavirus vaccine. Although the vaccine has been recommended for young women since 2007 and young men since 2015, the data indicates that age and gender remain the strongest predictors of whether an individual is protected. According to the Epidemiology, Biostatistics and Prevention Institute, while the vaccine is highly effective at preventing various cancers, its application among the adult population remains inconsistent and largely dependent on external medical advice.
Demographic Disparities in Vaccination Rates
The survey of over 3,800 adults aged 18 to 45 uncovered a sharp divide in uptake based on generational and gender lines. Nearly 60% of individuals in the 18 to 26 age bracket are vaccinated, but that figure drops to just 16% for those between the ages of 27 and 45. Furthermore, women are significantly more likely to be vaccinated than men, with rates of 43% and 12% respectively. First author Kyra Zens attributes these differences to the late introduction of the vaccine for males and the initial focus on adolescent girls, suggesting that current efforts must evolve to address these historical imbalances.
The Correlation Between Knowledge and Protection
Researchers categorized respondents into three distinct profiles based on their level of information regarding HPV and their general attitudes toward healthcare. The results showed a direct link between education and action, as 41% of well-informed individuals were vaccinated compared to only 8% of those with limited knowledge. Zens noted that vaccination decisions vary significantly depending on how a person assesses their personal risk and their understanding of the virus. This data suggests that increasing basic awareness of HPV as a common sexually transmitted infection is a fundamental step in raising national immunity levels.
Categories
Topics
Related Coverage
- University of Zurich Study Identifies Critical Gaps in Swiss Adult HPV Vaccination Rates Driven by Physician Guidance
- University of Zurich Study Identifies Sharp Decline in HPV Vaccine Uptake Among Swiss Adults Aged 27 to 45
- New data reveals persistent HPV infection risk in U.S. women over age 27, challenging vaccination age norms
- New mathematical modeling handbook launched by Swedish experts to standardize pandemic preparedness and decision-making